The Clorox Company
CLX
$138.78
$0.510.37%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.69B | 1.76B | 1.90B | 1.81B | 1.99B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.69B | 1.76B | 1.90B | 1.81B | 1.99B |
| Cost of Revenue | 950.00M | 956.00M | 1.02B | 1.05B | 1.12B |
| Gross Profit | 736.00M | 806.00M | 880.00M | 767.00M | 875.00M |
| SG&A Expenses | 467.00M | 483.00M | 381.00M | 506.00M | 494.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 4.00M | -14.00M | 202.00M | -5.00M | 9.00M |
| Total Operating Expenses | 1.45B | 1.46B | 1.64B | 1.58B | 1.65B |
| Operating Income | 234.00M | 306.00M | 264.00M | 234.00M | 340.00M |
| Income Before Tax | 237.00M | 177.00M | 275.00M | -42.00M | 136.00M |
| Income Tax Expenses | 43.00M | 74.00M | 54.00M | 8.00M | 40.00M |
| Earnings from Continuing Operations | 194.00M | 103.00M | 221.00M | -50.00M | 96.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.00M | -4.00M | -5.00M | -1.00M | -3.00M |
| Net Income | 193.00M | 99.00M | 216.00M | -51.00M | 93.00M |
| EBIT | 234.00M | 306.00M | 264.00M | 234.00M | 340.00M |
| EBITDA | 287.00M | 360.00M | 313.00M | 292.00M | 397.00M |
| EPS Basic | 1.56 | 0.80 | 1.74 | -0.41 | 0.75 |
| Normalized Basic EPS | 1.07 | 1.41 | 1.20 | 1.08 | 1.52 |
| EPS Diluted | 1.54 | 0.80 | 1.73 | -0.41 | 0.75 |
| Normalized Diluted EPS | 1.06 | 1.40 | 1.19 | 1.08 | 1.52 |
| Average Basic Shares Outstanding | 123.77M | 123.80M | 124.30M | 124.25M | 124.18M |
| Average Diluted Shares Outstanding | 124.66M | 124.68M | 125.05M | 124.25M | 124.62M |
| Dividend Per Share | 1.22 | 1.22 | 1.22 | 1.20 | 1.20 |
| Payout Ratio | 78.24% | 152.53% | 68.98% | -290.20% | 160.22% |